A study published online October 13, 2026, in the Journal of the American Academy of Dermatology tackles a question most dermatology practices never formally debate: should survey respondents get paid, and how much is too much?

The paper, "Is the Price Right? Ethical Considerations of Financial Incentives in Dermatology Survey Research," comes from Catherine S. Taghizadeh and Shari R. Lipner. It appeared online in JAAD on October 13, 2026.

Survey research underpins a large share of dermatology's evidence base, from physician preferences on biologics to patient-reported outcomes in psoriasis and eczema care. Incentives — cash, gift cards, donations — are a standard tool for boosting response rates. The ethics of paying respondents, however, has drawn little structured attention in the specialty's literature.

What does the paper actually examine?

Taghizadeh and Lipner work through the ethical tension at the center of the practice. Payments can raise participation and reduce non-response bias, which strengthens the generalizability of findings. That's the practical case for incentives.

The counterargument is coercion, or something close to it. An incentive large enough to sway a reluctant participant can compromise the voluntariness of consent — a concern that sharpens when surveys target patients with chronic inflammatory disease or when researchers recruit from economically vulnerable populations.

The authors frame the core question in their title: at what point does an incentive stop being a reasonable thank-you and start being an improper inducement?

Why does this matter for dermatology research?

Dermatology relies heavily on survey methodology. Preference studies, burden-of-disease work in conditions like psoriasis and atopic dermatitis, and practice-pattern surveys all depend on clinicians and patients answering questionnaires honestly and without pressure.

That makes incentive design a methodological issue, not just an ethical nicety. Get the payment wrong and you can distort who responds, what they report, and how far the results generalize — a validity problem hidden inside a recruitment tactic.

For dermatologists who run clinical research or sit on institutional review boards, the paper offers a framework for judging incentive levels against the population being surveyed and the sensitivity of the questions asked.

What's the takeaway for practicing dermatologists?

The study landed online October 13, 2026, in JAAD, authored by Catherine S. Taghizadeh and Shari R. Lipner. Its subject matter sits at the intersection of research ethics, methodology, and regulatory compliance — territory every dermatology department that fields surveys crosses sooner or later.

Whether the paper's analysis shifts IRB norms or journal policies on disclosed incentives remains to be seen. For now, it puts a long-standing, under-examined practice in the specialty on the record.